Search

everythinglearnresearchcommunity

for

Search:↓

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

Different treatments for alopecia areata have varying success rates and side effects; intralesional steroids are most effective.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Some drugs can cause hair loss, excessive growth, or color changes, often reversible but sometimes permanent.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Low dose oral minoxidil helps regrow hair in permanent chemotherapy-induced alopecia.

The skin is a complex barrier that protects the body, regulates temperature, and helps with immune responses.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.

Regulatory T cells are essential for normal and improved wound healing in mice.

Some medications might reverse gray hair, especially those that reduce inflammation or stimulate pigment production, and vitamin B might help.

Men are more affected by COVID-19 due to differences in immune responses and protein expression.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Antidepressants might help with skin inflammation and improve conditions like psoriasis and eczema.

Aromatic plants can naturally help prevent skin aging and improve skin health.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

The document concludes that computational models are useful for understanding immune responses and could improve cancer immunotherapy.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

People with alopecia areata have higher insulin resistance.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Effective treatments for severe alopecia areata are still lacking.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Some patients treated with peginterferon and ribavirin for chronic hepatitis C had mild to moderate skin reactions, but treatment did not need to be stopped.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Higher interleukin-15 levels are linked to more severe alopecia areata, but not to age or gender.

Diphencyprone is effective for treating patchy hair loss in alopecia areata, but tacrolimus is not.

COVID-19 can directly trigger certain skin conditions like pustular dermatoses due to an inflammatory response.